በTexas ለየጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጉበት ካንሰር (ሄፓቶሴሉላር ካርሲኖማ) የሚደረጉ 50 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በTexas ውስጥ ያሉ ከተሞች

Official study text (English)

A Study of ZW251 in Participants With Advanced Solid Tumors

MD Anderson Cancer Center, Houston
START San Antonio, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07164313

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #46, Austin
Exelixis Clinical Site #89, Dallas
Exelixis Clinical Site #73, Irving
እና 2 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05176483

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Research Facility, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06726161

National Liver Cancer Screening Trial

UT Southwestern Medical Center and Parkland Hospital, Dallas
Baylor College of Medicine, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 4

እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06084234

A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

The University of Texas Md Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06427941

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

M D Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT04380545

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

St. David's Medical Center, Austin

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ 22 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06486454

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT04864054

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Research Site, Amarillo
Research Site, Austin
Research Site, Houston
እና 2 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06921785

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

University of Texas Southwestern Medical Center, Dallas

ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07446257

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

START San Antonio, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦገስ 2026 · NCT06582017

Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

University of Texas Southwestern Medical Center, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT07689175

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

START-San Antonio, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT06084481

FOG-001 in Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics, LLC, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05919264

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Research Site, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT06795022

A Study of MGC026 in Participants With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas Health Science Center at Houston, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT06242470

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Texas Oncology - West Texas, Amarillo
Texas Oncology, P.A., Dallas
Texas Oncology Gulf Coast, Pearland

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT06330064

IDOV-Immune for Advanced Solid Tumors

MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT06910657

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Baylor Scott & White Research Institute, Dallas
University of Texas MD Anderson Cancer Center, Houston
Baylor Scott & White Medical Center, Temple

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 8 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT05503797

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
UT Southwestern Medical Center - Redbird, Dallas
Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
እና 8 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT05208762

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

M D Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ጁላይ 2026 · NCT05092373

Multi-analyte Blood Test Clinical Trial

South Texas Research Institute, Edinburg
Texas Gastro Research, El Paso
Impact Research Institute, Waco

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁላይ 2026 · NCT05199259

CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

University of Texas Southwestern Medical Center, Dallas

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁላይ 2026 · NCT06184152

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Clinical Trial Site, Dallas
Clinical Trial Site, Houston
Clinical Trial Site, San Antonio

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁን 2026 · NCT06600321

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Michael E. DeBakey VA Medical Center, Houston, TX, Houston

ተሳታዮችን በመፈለግ ላይ

እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁን 2026 · NCT05486572

A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma

The University of Texas M. D. Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT07116486

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

The University of Texas MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 16 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT07197554

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

M D Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ሜይ 2026 · NCT04982653

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

M D Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይ

እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT05053555

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA13-0, Anderson
USA12-0, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT06953089

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Harold C. Simmons Comprehensive Cancer Center, Dallas
University of Texas MD Anderson Cancer Center, Houston
DHR Health Institute for Research and Development, McAllen
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኤፕሪ 2026 · NCT05440708

Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines

M D Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT05143619

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

MD Anderson Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06362369

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Houston Methodist Hospital Cancer Center, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኤፕሪ 2026 · NCT05733598

Evaluation of Resection Techniques for Pancreatic Tumors

Methodist Dallas Medical Center, Dallas

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ማርች 2026 · NCT05128890

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

Oncology Consultants, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ16 ማርች 2026 · NCT07176650

Ligufalimab and Cadonilimab in Advanced Liver Cancers

University of Texas Southwestern Medical Center, Dallas

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ፌብሩ 2026 · NCT06789848

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Baylor College of Medicine, Houston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ ከ0 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ24 ፌብሩ 2026 · NCT04134559

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።